What is the effect of accompanying ankylosing spondylitis in treatment of Multiple Sclerosis? Is there a resistance
dc.authorid | 0000-0002-4988-1270 | |
dc.authorid | 0000-0002-5595-7251 | |
dc.authorid | 0000-0001-8140-6333 | |
dc.authorid | 0000-0001-7689-7131 | |
dc.authorid | 0000-0001-8986-155X | |
dc.contributor.author | Tezcan, Ezgi Akyıldız. | |
dc.contributor.author | Ekmekçi, Hakan. | |
dc.contributor.author | Özdemir, Gökhan. | |
dc.contributor.author | Gümüş, Haluk. | |
dc.contributor.author | Öztürk, Şerefnur. | |
dc.date.accessioned | 2020-03-26T20:19:45Z | |
dc.date.available | 2020-03-26T20:19:45Z | |
dc.date.issued | 2019 | |
dc.department | Selçuk Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Multiple sclerosis (MS) is an autoimmune central nervous system disease characterized by inflammation, demyelination, and axonal damage (1). Ankylosing spondylitis (AS) is a common inflammatory rheumatic disease affecting the axial skeleton, which can cause structural and functional disorders and decreased quality of life, and cause a characteristic back pain and position (2). The coexistence of MS and AS is rare. Besides the neurogenetic and neuroepidemiologic aspects of this association, there may be an interactive interaction in the treatment. It may be necessary to examine the effect of this situation on the roadmap to be followed in the treatment of both diseases. | en_US |
dc.identifier.citation | Tezcan, E. A., Ekmekçi, H., Özdemir, G., Gümüş, H., Öztürk, Ş. (2019). What is the Effect of Accompanying Ankylosing Spondylitis in Treatment of Multiple Sclerosis? Is there a Resistance?. Turkish Journal of Neurology, 25(3), 182-183. | |
dc.identifier.doi | 10.4274/tnd.galenos.2019.93206 | en_US |
dc.identifier.endpage | 183 | en_US |
dc.identifier.issn | 1301-062X | en_US |
dc.identifier.issn | 1309-2545 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | #YOK | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 182 | en_US |
dc.identifier.uri | https://dx.doi.org/10.4274/tnd.galenos.2019.93206 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/38389 | |
dc.identifier.volume | 25 | en_US |
dc.identifier.wos | WOS:000487283000016 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.institutionauthor | Tezcan, Ezgi Akyıldız. | |
dc.institutionauthor | Ekmekçi, Hakan. | |
dc.institutionauthor | Özdemir, Gökhan. | |
dc.institutionauthor | Gümüş, Haluk. | |
dc.institutionauthor | Öztürk, Şerefnur. | |
dc.language.iso | en | en_US |
dc.publisher | TURKISH NEUROLOGICAL SOC | en_US |
dc.relation.ispartof | TURKISH JOURNAL OF NEUROLOGY | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | Ankylosing spondylitis | en_US |
dc.subject | multiple sclerosis | en_US |
dc.subject | demyelination | en_US |
dc.title | What is the effect of accompanying ankylosing spondylitis in treatment of Multiple Sclerosis? Is there a resistance | en_US |
dc.title.alternative | Multipl Sklerozda eşlik eden ankilozan spondilitin tedaviye etkisi ne düzeydedir? Bir direnç söz konusu olabilir mi | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- Ezgi Akyıldız TEZCAN.pdf
- Boyut:
- 164.74 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Full Text Access